HC Deb 02 April 2001 vol 366 cc38-9W
Dr. Tonge

To ask the Secretary of State for Health what discussions he has had with the World Drug Federation regarding the closure of the Bayer plant in the USA. [156358]

Mr. Denham

I have had no discussion with the Food and Drugs Administration (FDA). The Medicines Control Agency (MCA) has discussed the temporary curtailment of supply of the Bayer synthetic Factor VIII product with the European Medicines Evaluation Agency (EMEA). It is licensed by the EMEA under the European centralised licensing procedure and accordingly the agency has responsibility in Europe for co-ordinating relevant licensing issues. The MCA understands that the EMEA was only recently advised of these supply problems.

Forward to